Pemigatinib
Back to searchMolecule Structure
Scientific Name
Pemigatinib
Description of the Drug
Pemigatinib is a kinase inhibitor used to treat locally advanced or metastatic, unresectable cholangiocarcinoma in previously treated adult patients.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB15102
http://www.drugbank.ca/drugs/DB15102
Brand Name(s)
Pemazyre
Company Owner(s)
Incyte Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Fibroblast growth factor receptor 1 | SINGLE PROTEIN | INHIBITOR | CHEMBL3650 |
Fibroblast growth factor receptor 2 | SINGLE PROTEIN | INHIBITOR | CHEMBL4142 |
Fibroblast growth factor receptor 3 | SINGLE PROTEIN | INHIBITOR | CHEMBL2742 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL15556271 | |
Human Metabolome Database | HMDB0304863 | |
DrugBank | DB15102 | |
PubChem | 86705695 | |
PDBe | 8ZF | |
BindingDB | 301310 | |
DrugCentral | 5390 | |
ChemicalBook | CB54796678 | |
Guide to Pharmacology | 9767 | |
rxnorm | PEMIGATINIB | PEMAZYRE |